http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4151184-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c902faf6ae746c51fc8010672fc22894
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-935
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D263-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-5407
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C405-0016
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C405-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-4059
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-4006
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C405-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-94
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D263-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-935
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-23
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C67-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D317-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C401-00
filingDate 1977-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1979-04-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5587f688f245b454076f9c167fcf61ed
publicationDate 1979-04-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-4151184-A
titleOfInvention 2,2-Difluoro-13,14-didehydro-PGE1 compounds
abstract This invention comprises certain analogs of the prostaglandins in which the double bond between C-13 and C-14 is replaced by a triple bond. A so provided in this invention, are novel chemical processes and novel chemical intermediates useful in the preparation of the above prostaglandin analogs. These prostaglandin analogs exhibit prostaglandin-like activity, and are accordingly useful for the same pharmacological purposes as the prostaglandins. Among these purposes are blood pressure lowering, labor induction at term, reproductive-cycle regulation, gastric antisecretory action, and the like.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11478578-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10578098-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11384748-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10670005-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10590924-B2
priorityDate 1976-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3933899-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3914282-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3931411-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3933889-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3959346-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3932463-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3962293-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457192620
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457280508
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783

Total number of triples: 50.